Asia Deal Watch: GC Pharma Looks To Build On Enzyme Replacement Therapy Success

Plus, Takeda, PeptiDream Expand Collaboration

South Korean firm teams with Speragen to develop enzyme-replacement therapy for the genetic disorder and with Mirum for maralixibat. Plus deals involving Takeda/PeptiDream, Hanmi/LegoChem, Sun/Cassiopea, LegoChem/Cellectar, ChubLab/CJ CheilJedang Corp., Alebund/Chugai, Kintor/Fosun, Astellas/ExCellThera and I-Mab/neoX/Immorna.

Asia Deal Watch

More from Deal Watch

More from Deals